-
Mashup Score: 0This Week in Digital Health Funding - $800 Million - 4 hour(s) ago
This week, approximately $793,440,000 was raised in healthcare funding. The largest rounds were the $200 million Series C for Zenas BioPharma and the $182 million Series C for Bluejay Therapeutics.
Source: www.linkedin.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 4
Drug discovery is an incredibly daunting task. The needle in a haystack analogy might be a bit overused, but it’s an apt way to describe the challenge of identifying a promising drug target in a tangle of biological pathways.
Source: www.linkedin.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
Wanna learn Machine Learning 𝗳𝗮𝘀𝘁𝗲𝗿 ⚡? Here is how ↓ 𝗧𝗵𝗲 𝗻𝗲𝗲𝗱 𝘁𝗼 𝗰𝗼𝗻𝘀𝘁𝗮𝗻𝘁𝗹𝘆 𝗹𝗲𝗮𝗿𝗻 𝗠𝗟 🔄 Machine Learning is an exciting…
Source: www.linkedin.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 1[Video] Will Flanary on LinkedIn: Internal medicine rounds. - 3 day(s) ago
Internal medicine rounds.
Source: www.linkedin.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Mayo Clinic Health System on LinkedIn: In recognition of a generous $3.5 million gift to Mayo Clinic Health… - 3 day(s) ago
In recognition of a generous $3.5 million gift to Mayo Clinic Health System, the Madison East Health Campus breast clinic in Mankato, Minnesota, has been…
Source: www.linkedin.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Heather Costley on LinkedIn: Happy Nurses Week Congratulations to the recipients of the MCHS NWWI… - 3 day(s) ago
Happy Nurses Week Congratulations to the recipients of the MCHS NWWI Nurses Week Awards Special thanks to Tom Kidd for the message on living the “rest of…
Source: www.linkedin.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8Updates in Thrombosis Management:The Emerging Role of Factor XI Inhibition | LinkedIn - 3 day(s) ago
See who else is going to Updates in Thrombosis Management:The Emerging Role of Factor XI Inhibition, and keep up-to-date with conversations about the
Source: www.linkedin.comCategories: General Medicine News, Cardiology News and JournTweet-
❓ What’s next in thrombosis management? Join @GBarnesMD and @manesh_patelMD in this LIVE social media event as they discuss the gaps in thrombosis management and share their thoughts on the emerging role of factor XI inhibition. Register your interest ➡️ https://t.co/a6JObufehq https://t.co/FhTQGvEjjJ
-
-
Mashup Score: 8Alexander Kutikov, MD, FACS on LinkedIn: 🌟 Join Our Team at Fox Chase - Temple Urologic Institute 🌟 Position:… - 4 day(s) ago
🌟 Join Our Team at Fox Chase – Temple Urologic Institute 🌟 Position: PHYSICIAN ASSISTANT (FT; 40hrs/wk) – Urology / Urologic Oncology at Jeanes Hospital…
Source: www.linkedin.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Endocrine Connections | LinkedIn - 4 day(s) ago
Endocrine Connections | 5 followers on LinkedIn. An open-access, society-owned journal. Publishing basic, translational and clinical research in endocrinology. | Endocrine Connections is an open-access, peer-reviewed journal, owned by the Society for Endocrinology and the European Society of Endocrinology. It publishes basic, translational and clinical research and reviews in all areas of endocrinology. The journal is led by Professor Faisal Ahmed, from the School of Medicine, Dentistry & Nursing, University of Glasgow, UK, alongside an international editorial board.
Source: www.linkedin.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 3Rob Brierley on LinkedIn: #worldhepatitissummit #gastroenterology #hepatology #medicine - 4 day(s) ago
The June issue of The Lancet Gastroenterology & Hepatology is out now at https://lnkd.in/eACvnEez! This month’s cover, by Marta Lanuza, focuses on one of the…
Source: www.linkedin.comCategories: General Medicine News, GastroenterologyTweet
This week, approximately $793,440,000 was raised in #healthcare funding. The largest rounds were the $200 million Series C for Zenas BioPharma and the $182 million Series C for Bluejay Therapeutics. https://t.co/iwNrXb57QU https://t.co/DTkcAK7rDT